The proposal sits in their inbox for three days. Then a week. Then comes the dreaded “we've decided to hold off for now” email.

You know you can solve their problem. The pricing makes sense. But something invisible is blocking the sale.

It's not your offer. You put in the work to build a great one.

No, not the offer. It's the anxieties your buyer has, but won't say out loud.

They're wondering if you'll actually deliver. Whether you're the right fit for their situation. If switching to you creates more headaches than it solves.

These doubts don't show up in email threads or discovery calls, but they kill deals just the same.

Without a chance to discuss it, you don’t have a chance to counter it. 

Thus, you need to build proof, clarity, and friction-reduction into every touchpoint, countering the objections before they tank your sale.

In this newsletter:

The Dell Pro Max mobile lineup, built in collaboration with NVIDIA and powered by the RTX PRO GPUs, delivers desktop-level AI performance in a form you can actually take with you. From model training to deployment, you’ll move faster, experiment more, and work wherever you need to be. No bottlenecks, and no desk required.

When Derrick Reimer launched SavvyCal, he was entering a tightly held market. Calendly basically owned scheduling. While other competitors had years of head starts, bigger teams, and established user bases.

Reimer had something else, though. 

He'd co-founded and sold his old company, Drip, to Leadpages, so he understood high-pressure sales. He knew what made buyers hesitate. Was familiar with the fact that invisible, conversation-killing friction wasn't about features or pricing.

It was about unspoken fears.

So he built SavvyCal accordingly. He wanted to preemptively answer every doubt a prospect might have, before they ever had to voice it. Not by hopping on sales calls or creating email sequences, but through the product experience itself.

Before we get into the specifics… the tactics worked. SavvyCal reportedly crossed $1M ARR with a tiny team and minimal outside funding. Here are the anxieties he addressed.

Can I trust this company to deliver?

SavvyCal's site is polished. Not flashy, but intentionally designed to signal competence. Testimonials appear early, with specific quotes about the scheduling experience rather than vague praise.

The product demo is functional immediately. No gated trial that requires a sales call. You can test the core value within minutes of landing on the site.

Every design choice whispers: “We know what we're doing.”

Is this actually right for my situation?

SavvyCal doesn't try to be everything to everyone. The positioning is specific: it's for people tired of the power imbalance in traditional scheduling tools.

Features like calendar overlays, per-link customization, and meeting limits make it obvious who benefits. If you need basic scheduling, Calendly is probably fine. If you want control and flexibility, SavvyCal is built for you.

The product itself answers the fit question. No need for a “who is this for?” FAQ buried on a pricing page.

Will this actually solve my problem?

Most scheduling tools promise to “save time” or “reduce back-and-forth.” SavvyCal shows, instead of telling.

Calendar overlays let invitees see your availability and theirs side-by-side. Meeting limits prevent calendar overload. Multiple duration options per link eliminate the need for separate booking pages.

These aren't features listed in a comparison chart. They're features you experience in the first five minutes of use.

What if switching is a nightmare?

This is where SavvyCal made its boldest move.

On their website: “We'll buy you out of your annual Calendly subscription.”

You forward your Calendly receipt. They credit the remaining value toward a SavvyCal annual plan. The switching cost drops to nearly zero.

They also offer a seven-day free trial with easy calendar imports. No lock-in, complicated migration process, or sales pressure.

Most founders audit their buyer journey backwards. They look at where deals die and try to patch those holes.

That's reactive. And expensive.

The more efficient approach is understanding when each anxiety peaks, then designing your touchpoints to address concerns before they calcify into objections.

Here's how to do it:

List every interaction a prospect has with you before they buy:

Write them in chronological order. This is your current buyer journey.

Estimate how far along the buyer’s decision process each touchpoint falls:

Don't overthink this. Rough estimates work fine.

Research shows each anxiety peaks at predictable moments. Map yours accordingly:

Must be addressed BEFORE first contact through:

If credibility isn't established early, buyers never reach out. 79% already know which product they'll buy before starting research.

Peaks during active evaluation:

This is iterative. Keep validating fit as you learn more about your ICP.

Peaks when building the business case:

Very few buyers find ROI easy to calculate. Make it easier than your competitors do.

The late-stage killer. Address it early:

Half of all deals end in "no decision" because implementation anxiety goes unaddressed. The optimal time to tackle it is 50-60% through the journey, before fear paralyzes the process.

For each touchpoint, ask which anxieties it addresses. For example, your analysis may look like this:

The pattern will reveal your gaps.

Research shows you cannot skip the sequence: credibility enables fit discussions, fit enables outcome conversations, outcomes enable implementation planning.

Look for two specific problems:

If prospects aren't reaching out, you're failing the 0-40% credibility test.

Fix: Add specific customer outcomes to your homepage. Not "trusted by thousands" but "helped Company X reduce churn by 34% in 90 days."

If deals stall at 70-85%, you're not addressing effort/risk early enough.

Fix: At your 50-60% touchpoint (usually discovery or proposal), proactively present:

Most vendors wait for buyers to ask about implementation. By then, anxiety has already set in. Addressing it at 50-60% positions implementation as your competitive advantage, rather than a late-stage objection.

Pick the stage where most deals currently die. Track whether proactively addressing the relevant anxiety moves deals forward.

If it does, perfect. Time to do it again.

Move to the next stage, repeat the process, and watch your conversion rates rise.

On New Year’s Eve 2006, Death & Co’s opening night, its signature cocktails cost $12. Now Death & Co is offering that pricing for life to select investors.

But the real opportunity in owning Death & Co stock isn’t just the cocktail price, it’s sharing in the company’s growth potential.

They attract 10,000+ weekly bar visitors and project to make over $20M this year. And that’s just the start. They project revenue will grow 5.5X in just four years.

The award-winning hospitality brand is currently opening new bars and hotels in major US cities and international locations, with their newly debuted boutique hotel in Savannah attracting national media attention.

As a thank you for joining their investor community, Death & Co is offering exclusive benefits to shareholders, including investor happy hours, priority reservations, $12 cocktails for life, and more.

But the investment window ends on October 30, so you don’t have time to wait.

Become a Death & Co shareholder while you can.

_{This is a paid advertisement for Death & Company’s Regulation A offering. Past performance is not indicative of future results. Please read the offering circular at invest.deathandcompany.com.}